Nuvectis Pharma
NVCT
NVCT
37 hedge funds and large institutions have $20M invested in Nuvectis Pharma in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.63% more ownership
Funds ownership: 3.19% → 7.83% (+4.6%)
Holders
37
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.81M | |
| 2 | +$1.47M | |
| 3 | +$1.24M | |
| 4 |
JMFC
J.M. Forbes & Co
Boston,
Massachusetts
|
+$1.07M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.03M |
Top Sellers
| 1 | -$858K | |
| 2 | -$323K | |
| 3 | -$168K | |
| 4 |
Jane Street
New York
|
-$145K |
| 5 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
-$27.9K |